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Abstract
Background: Prolonged need for intensive care is associated with neuromuscular weakness, termed Intensive Care
Unit Acquired Weakness. Those affected suffer from severe functional impairment that can persist for years. First
studies suggest a positive effect of physiotherapy and early mobilisation. However, the ideal intervention for a
preferential functional outcome is not known. So far no randomised controlled trial has been conducted to
specifically evaluate an early endurance and resistance training in the mechanically ventilated, critically ill patient.
Methods/design: A randomised controlled trial with blinded assessors and 6-month follow-up will be conducted
in a tertiary, interdisciplinary intensive care unit in Switzerland. Participants (n = 115; expected dropouts: n = 15) will
be randomised to a control group receiving standard physiotherapy and to an experimental group that undergoes
early mobilisation combined with endurance and resistance training. The inclusion criteria are being aged 18 years
or older, expected mechanical ventilation for more than 72 h and qualitative independence before the illness.
Primary endpoints are functional capacity (6-Minute Walk Test) and the ability to perform activities of daily living
(Functional Independence Measure) measured at hospital discharge. Secondary endpoints include muscle strength
(Medical Research Council sum score, handgrip strength and handheld dynamometry for quadriceps muscle), joint
contractures (range of motion), exercise capacity (Timed ‘Up & Go’ Test) and health-related quality of life (Short
Form 36). Safety will be monitored during interventions by indirect calorimetry and continuous intensive care
standard monitoring. All previously defined adverse events will be noted. The statistical analysis will be by
intention-to-treat with the level of significance set at p < 0.05.
Discussion: This prospective, single-centre, allocation-concealed and assessor-blinded randomised controlled trial
will evaluate participant’s function after an early endurance and resistance training compared to standard care.
Limitations of this study are the heterogeneity of the critically ill and the discontinuity of the protocol after
relocation to the ward. The strengths lie in the pragmatic design and the clinical significance of the chosen
outcome measures.
Trial registration: German Clinical Trials Register (DRKS): DRKS00004347, registered on 10 September 2012.
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illness
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Background
Intensive care unit (ICU) survivors have a persistently
high mortality and an exceedingly poor quality of life
that manifests itself up to 5 years after ICU discharge
[1]. Further burdens include exercise limitation, physical
and psychological complications as well as increased
costs and use of health care services [2]. To outline
these multiple long-term consequences after survival of
a critical illness the term post intensive care syndrome
(PICS) has been agreed on [3]. Consequently, PICS de-
scribes impairments in physical, cognitive or mental
health status subsequent to a critical illness and persist-
ing beyond hospital discharge.
Intensive Care Unit Acquired Weakness (ICUAW)
Neuromuscular dysfunctions are an important aspect of
the physical impairment following ICU stay and are
probably a crucial contributor to the associated long-
term disability. They are common in critically ill
patients requiring more than 1 week of mechanical ven-
tilation and have an approximate incidence of 40 % [4].
A simple framework to diagnose and classify these
neuromuscular disorders has been proposed [5]. Hence,
the term ‘Intensive Care Unit Acquired Weakness’
(ICUAW) describes a clinically detected weakness in
critically ill patients with no plausible aetiology except
for the critical illness itself. ICUAW is associated with
worse outcomes such as prolonged weaning from
mechanical ventilation [6], weaning failure with a high
occurrence of reintubation or tracheotomy [7], longer
ICU and hospital stays [8], increased ICU and hospital
mortality [9], increased mortality 180 days after ICU
discharge [10] in addition to poor functional status,
persistent disability in activities of daily living, reduced
walking ability and lower quality of life up to 1 year
after ICU discharge [11–14] The underlying patho-
physiological mechanisms of ICUAW are complex and
poorly understood. Several risk factors, in particular,
high severity of illness with multiorgan failure, hyper-
glycaemia and immobilisation, contribute to the devel-
opment of ICUAW [15]. The process of muscle wasting
begins during the first week of a critical illness and thus
commences very early and rapidly [16]. So far there is
no specific treatment for ICUAW. However, the poten-
tial benefit of early rehabilitation and physiotherapy has
been suggested by a recent Cochrane review [17].
Rehabilitation in intensive care
Physiotherapists are seen as an essential part of the
multidisciplinary ICU team [18]. Compared to other
health care professionals they can be more successful in
facilitating early mobilisation and rehabilitation in critic-
ally ill patients [19]. Their specific knowledge of neuro-
logical and musculoskeletal conditions enables the
physiotherapist to assess current rehabilitation needs, to
detect early deficits, such as ICUAW, and to set rehabili-
tation goals accordingly [18]. Consequently, physiothera-
pists seem ideal to meet the recommendations of the
National Institute for Health and Care Excellence
(NICE) for an individualised, structured rehabilitation
programme with frequent follow-up reviews during crit-
ical illness [20]. However, there are only a few rando-
mised controlled trials to support this statement. One
randomised controlled trial was conducted by Burtin
and colleagues in a medical and surgical ICU and
involved 90 patients with a prolonged ICU stay [21]. Par-
ticipants were randomised into standard physiotherapy
alone and standard physiotherapy plus an additional bed
cycling training 5 days a week. At hospital discharge the
6-minute walking distance, isometric quadriceps force
and the Physical Functioning score of the Short Form 36
(SF-36) were significantly higher in the cycling group.
Similarly, Schweickert and colleagues conducted a ran-
domised controlled trial in a medical ICU with 104
mechanically ventilated patients [22]. They found that
physiotherapy, specifically very early exercise and mobil-
isation, during periods without sedation led to more pa-
tients returning to functional independence at hospital
discharge compared to usual care, and led to fewer days
with delirium and mechanical ventilation. However, an-
other randomised controlled trial with 150 participants
comparing usual care to intensive exercise that started
5 days after ICU admission, continued during the stay in
the ward and for 8 weeks in an outpatient setting, failed
to show any benefit for intensive exercise therapy [23].
Finally, a randomised controlled trial, including 50 pa-
tients with sepsis syndrome, compared an individualised
physical rehabilitation programme starting within 48 h
after sepsis diagnosis to standard care without active re-
habilitation [24]. There was no significant difference in
physical function at ICU discharge, but individuals in
the intervention group reported an improvement in
physical function and physical role 6 months after hos-
pital discharge on the SF-36.
Given the discrepancies of the findings in the previ-
ous few studies, further research to evaluate the long-
term outcome of early rehabilitation interventions
seems necessary. Future studies should be performed
with high methodological quality and report the admin-
istered frequency, intensity and timing of the interven-
tions [17, 25]. To our knowledge no randomised
controlled trial has so far been conducted to evaluate
the efficacy of early physiotherapeutic interventions, in-
cluding both an endurance and resistance component,
in the mechanically ventilated, critically ill patient. Aer-
obic and strength training are widely recommended
and are effective interventions in chronic diseases and
disabilities like stroke [26], chronic heart failure [27],
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older adults’ disabilities [28], chronic obstructive pul-
monary disease [29] and cancer-related fatigue [30]. We
expect a similar benefit in critical illness. To avoid the
limitations of previous studies, we aim to include par-
ticipants from a general ICU population, containing pa-
tients at risk of a prolonged ICU stay and ICUAW as a
consequence. Also, and because ICUAW develops early
and rapidly, the goal is to start early with low-intensity
exercise that will be increased according to the patient’s
level of tolerance until full mobilisation.
Study purpose
This study aims to investigate the effects and safety of
an early endurance and resistance training combined
with early mobilisation in comparison to standard care
in critically ill, mechanically ventilated adults at an inter-
disciplinary, tertiary ICU.
Hypotheses
The primary hypothesis is that critically ill, mechanically
ventilated adults who participate in an early endurance
and resistance training, combined with early mobilisa-
tion, have an improved functional capacity and are,
therefore, more functionally independent at hospital dis-
charge compared to patients receiving the usual physio-
therapy care. Secondary hypotheses are that this early
training is as feasible and as safe as standard therapy.
Further, we expect improvements in muscle strength at
ICU discharge, fewer joint contractures, less time on
mechanical ventilation, a shorter length of stay in the
ICU and the hospital, and a higher quality of life at
6 months after hospital discharge compared to patients
receiving usual care.
Methods and design
We will conduct a prospective, single-centre, allocation-
concealed and assessor-blinded randomised controlled
trial with superiority design and 6-month follow-up. The
study has been approved by the Ethics Committee of
Canton Bern (KEK), Switzerland and is registered in the
German Clinical Trials Register (DRKS00004347). This
trial adheres to the recommendations from the Consoli-
dated Standards of Reporting Trials (CONSORT) state-
ment [31] (Fig. 1) and is conducted according to Swiss
law and Good Clinical Practice (GCP) guidelines.
Study population
The study is being conducted in the tertiary, interdiscip-
linary ICU of the Department of Intensive Care Medi-
cine at the Inselspital, Bern University Hospital. To be
eligible to participate in the study patients must be aged
18 or older, be expected to stay on mechanical ventila-
tion for at least 72 h, which reflects a prolonged stay at
our unit, and finally, participants must have been
independent in their activities of daily living before the
onset of critical illness (verbal statement by their proxy).
Patients with prior muscle weakness, such as a preexist-
ing neurological or neuromuscular disease with func-
tional deficits or a prolonged stay in the hospital for at
least 10 days prior to the ICU admission, are excluded
from the study. Further exclusion criteria are contraindi-
cations to cycling (mainly fractures or recent surgical
procedures to the lower limbs, acute thrombosis, preex-
isting open wounds, extracorporeal membrane oxygen-
ation (ECMO) and body weight of more than 150 kg),
patients who are already enrolled in another intervention
study, patients receiving palliative care, patients with a
diagnosis on admission that excludes the possibility of
walking at hospital discharge (for example, paraplegia)
and lastly patients who do not understand either
German or French.
Standard care (control group)
Participants randomised to the control group will re-
ceive usual physiotherapy and ICU standard care, which
includes sedation and weaning protocols based on previ-
ous publications [32]. Current physiotherapy practice is
comparable to the European norm [33] consisting of po-
sitioning, respiratory therapy, passive range of move-
ment exercises for nonresponsive patients or active
exercises if arousable, and early mobilisation. In order to
start as early as possible, physiotherapists screen patients
regularly focussing on prevention and treatment of func-
tional and pulmonary impairment. However, subject to
our internal procedure, physiotherapy and mobilisation
will start after medical prescription. Treatments are
based on the therapist’s assessment and are accordingly
individually tailored. Sessions will usually take place
once daily from Monday to Friday and, if deemed neces-
sary (e.g. severe weakness, intensive rehabilitation and
weaning period, retained airway secretion or atelectasis
in extubated patients), this includes treatment at the
weekend.
Study intervention (experimental group)
Patients randomised to the experimental group will re-
ceive a standardised exercise programme involving early
endurance and resistance training that is combined with
early mobilisation. The clinician in charge will decide
before study inclusion, whether there are any contraindi-
cations to include the patient, and during the study, if at
any time the treatment should be stopped, e.g. in case of
an adverse event (see safety). Therefore, the intervention
will be started as soon as it is deemed safe by the treat-
ing ICU team and will occur from Monday to Friday
and, if deemed necessary, at the weekend. Throughout
all activities, progression will be increased successively,
depending on an individual’s tolerance and stability. If
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needed, the physiotherapist will split the delivery of the
exercise programme into one or more sessions (Fig. 2).
The number of treatments, its content and duration will
be noted for both the control and experimental group.
Endurance training will be conducted with a motor-
assisted bedside cycle ergometer that allows patients to
train in a passive, motor-assisted or active mode from a
hospital bed (MOTOmed letto2, Reck-Technik, GmbJ &
Co. KG, Betzenweiler, Germany) (Fig. 3). Training inten-
sity has been adapted from a previous study with long-
term ICU patients from Burtin and colleagues [21].
Thus, the aim for unresponsive patients will be one pas-
sive training of 20 min with a fixed pedalling rate of
20 cycles per minute from Monday to Friday. In the
course of cycling, patient’s participation will be prompted
verbally and by the integrated MOTOmed ServoCycling
feature. After achieving patient’s active partaking, the goal
will be to train with motor assistance for at least 20 min
on level 0. If this is accomplished, assistance will be grad-
ually decreased and subsequently, resistance level and
training period increased until a maximum of 60 min on
level 6. Tolerance and stability will be judged by the re-
sponsible physiotherapist according to patient’s perceived
level of exertion (BORG RPE Scale) [34] and especially in
unresponsive patients, exceedence of individually set
limits. The training position will be supine with an indi-
vidually adapted head-of-bed elevation to allow for leg
movement and comfort.
The resistance training will consist of an individually
tailored exercise programme as well as standardised
Fig. 1 Study flow diagram (CONSORT) [31]. Legend: RCT, randomised controlled trial
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exercises for both upper and lower limbs and will train
the muscle groups for shoulder flexion, shoulder exter-
nal rotation, elbow flexion, hip abduction, knee exten-
sion and foot dorsiflexion. The resistance will be
administered by the therapist or with weights, starting
from 450 g. Training intensity will aim to achieve 50 to
70 % of the estimated one-repetition-maximum, with a
goal of 8 to 12 repetitions and 2 to 5 sets with at least a
2-min rest between series. If a participant is able to per-
form the exercises correctly, he will be given a tutorial
with pictures in order to train independently with nurses
or family members. If unable to perform the exercises,
the physiotherapist will use tactile facilitation or passive
range of movement for all joints and their possible
directions.
If the previous exercises are well-tolerated, bed mobil-
ity and sitting upright in bed will be started (Fig. 4). If
these are well-tolerated and no contraindications as per
medical prescription exist, the treatment will be further
advanced to mobilising participants to the bedside.
There, balance exercises will be performed or, if needed,
support will be provided by the physiotherapist or
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Fig. 2 Daily physiotherapy screening and step progression (experimental group). Legend: ICUAW, Intensive Care Unit Acquired Weakness
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various assistive equipment. After being able to sit for at
least 10 min on the side of the bed, regardless of
whether support is needed, participants will be moved
into a chair with an individually adapted transfer accord-
ing to the individual’s resources. The aim during all
mobilisations will be to involve the patient as actively as
possible to promote independence. While sitting, func-
tional tasks and activities of daily living will be per-
formed and gradually increased to standing and walking
exercises.
Safety
To ensure the patient’s safety all vital parameters, particu-
larly heart rate, invasive blood pressure and oxygen satur-
ation, will be continuously monitored and recorded by
our Patient Data Management System (PDMS), which is
routinely checked by the ICU staff. Furthermore, oxygen
consumption, energy expenditure and the respiratory quo-
tient by indirect calorimetry will be obtained 30 min prior
to, during and for 15 min after physiotherapy. All adverse
events (AE) will be noted. These are defined as any event
that occurs during or up to 15 min after physiotherapy
and persists despite an intervention or therapy interrup-
tion. It includes new haemodynamically relevant arrhyth-
mias or otherwise unstable haemodynamics, oxygenation
desaturation under 85 %, a fall or other injury as well as
any accidental removals of a tube, catheter or similar
devices. We use a qualitative physiological approach in-
stead of strict target numbers, as optimal physiological
goals for individual patients vary highly and depend on
the underlying clinical condition [32]. If a participant ex-
ceeds or fails to exceed his individually set limits, the ther-
apist will discontinue the session for the day and will
record the reason. If this happens repeatedly, the principal
investigator will withdraw the patient from the study. Ser-
ious adverse events (SAE) are defined as death, a life-
threatening injury or an extension of the length of hospital
stay. All SAEs and AEs will be recorded and reported to
the principal investigator, who judges their severity and
whether they were study-related. All SAEs will also be re-
ported to the local ethics committee. Finally, all occurring
complications related to bed rest, such as atelectasis,
pneumonia, decubitus ulcer, thrombosis, contracture, de-
lirium and a confirmed critical illness, polyneuropathy or
myopathy, will be judged and recorded daily by the treat-
ing physician according to our current standard of care.
Fig. 3 Early endurance training with a bedside cycle ergometer.
Picture: Pascal Gugler, Inselspital, Bern University Hospital
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Fig. 4 Mobilisation levels (experimental group)
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Study duration
The study intervention will take place during the entire
ICU stay as well as during potential readmissions to the
ICU. Therefore, the study duration will be variable for
each patient. After ICU discharge both groups will re-
ceive the usual physiotherapy treatment and, if neces-
sary, rehabilitation. Likewise, there will be no difference
for participants of both groups in terms of medical at-
tention, treatment and care during the whole study dur-
ation. The study will finish with a follow-up 6 months
after hospital discharge.
Outcome
The primary outcome measures are functional capacity
using the 6-Minute Walk Test (6MWT) [35] and the
ability to perform activities of daily living using the
Functional Independence Measure (FIM) [36]; both will
be evaluated at hospital discharge.
The secondary outcome measures were chosen to re-
flect the physical impairment after ICUAW and whether
these important clinical outcomes can be improved by
early training. They are as follows:
Muscle strength and ICUAW diagnosis at ICU discharge:
Medical Research Council sum score [5, 37], handgrip
strength using the JAMAR dynamometer (Sammons
Preston Rolyan, Bolingbrook, IL, USA) [37, 38] and quadri-
ceps muscle strength using a handheld dynamometer
(Microfet 2, Biometrics, Almere, Netherlands) [38]. Muscle
strength tests will only be performed if a patient can follow
three out of five simple commands in order to assess their
ability to cooperate as well as the level of consciousness be-
forehand [39].
Joint contractures, which are defined as limitations in
range of motion, will be recorded after ICU discharge
for the following joints: shoulder flexion, elbow flexion
and extension, fist closure, hip flexion, knee flexion and
extension and foot dorsiflexion [40].
Functional mobility will be measured with the Timed
‘Up & Go’ Test [41] at hospital discharge.
The quality of life 6 months after hospital discharge
will be assessed with the Short Form 36 (SF-36, version
1.3) [42].
The overall time on mechanical ventilation, length of
stay in the ICU and the hospital, as well as achieved
milestones during the ICU stay (sitting on the side of
the bed, sitting in a chair, standing or walking) will be
reported.
Furthermore, the safety of early training, particularly
the physiological response of the participants, any oc-
curring AE, SAE and other complications related to
bed rest as well as the feasibility, frequency, duration
and content of the therapy, will be collected and
analysed.
The schedule for the outcome assessments is shown in
Table 1.
Recruitment, randomisation and blinding
Patients will be screened daily after their ICU admission
for study eligibility by the physiotherapist and research
nurse in charge and will be included after consultation
with the responsible clinician. Reasons for nonrecruit-
ment will be noted in a daily screening log. If a patient is
considered eligible a nonparticipating doctor will reex-
amine the inclusion and exclusion criteria in order to
safeguard the patients’ interests according to Swiss law
on nonresponsive patients. Participants will then be
randomised at a 1:1 ratio to either the experimental or
control group by the responsible research nurse using
sequentially numbered, opaque, sealed envelopes to en-
sure a concealed allocation [43]. The allocation sequence
was generated in advance by a study nurse using unrest-
rictive computer-generated randomisation. Furthermore,
according to the recommendations of Good Clinical
Practice (GCP) the willingness to participate will be
obtained in the form of a presumed consent from the
patients’ proxy within 72 h (Table 1). After regaining the
power of judgement, patients will be informed of the
study in writing and asked retrospectively by a GCP-
trained physician to provide written informed consent.
Participants have the right to withdraw from the trial at
any given time. If unwilling to participate or withdraw-
ing from the trial, patients will be excluded from the
study and asked if the data that has already been col-
lected may be retained. The sample size will be adjusted
for dropouts.
Due to the nature of the intervention it is not possible
to maintain blinding for the treating physiotherapists,
ICU staff or participants. However, the group of physio-
therapists who will assess the main outcomes will be
distinct from the treating therapists and will, therefore,
be blinded to group allocation.
Sample size
For patients with chronic obstructive lung disease the
minimal clinically important difference for the 6MWT
has been validated at 54 m [44]. Using this threshold
and a mean walking distance of 301 m (SD 81) [45] a
sample size calculation based on a statistical power of
80 % and an α-level of 0.05 requires a sample size of 36
participants per group, i.e. a total of 72 patients for the
study. We expect a high correlation between the two
primary outcomes and, therefore, only moderately cor-
rected the size upwards by 14 patients each. We assume
a dropout rate of 15 % and adjusted the sample size by
15, resulting in a total number of 115 patients. However,
we obtained the approval of the Ethics Committee to
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recruit more patients, if needed, to compensate for a
higher number of dropouts (denied informed consent).
Data collection and management
Table 1 gives an overview of the data to be collected and
the time of acquisition, including routinely gathered data
such as demographics (age, gender, weight, body mass
index), severity of illness (Acute Physiology and Chronic
Health Evaluation (APACHE) II score, Therapeutic
Intervention Scoring System (TISS28 und TISS76),
Sequential Organ Failure Assessment (SOFA) score,
diagnostic data as well as laboratory findings and dose
and type of sedation, relaxants, vasopressors, opiates,
steroids and insulin.
All study data will be collected anonymously with an
individually allocated study number on all case report
forms and will be managed using REDCap (Research
Electronic Data Capture) electronic data capture tools,
which is a secure, web-based application designed to
support data capture for research studies [46]. Vital pa-
rameters for the safety analysis will be collected by the
aforementioned PDMS, which allows for continuous
data collection and off-line analysis.
Statistical analysis
Study data will be analysed as randomised with SPSS
(IBM SPSS Statistics Version 21) by both intention-to-
treat (main analysis) and per-protocol analysis. How-
ever, the intention-to-treat analysis will only include
participants with an informed consent, as adjusted in
the sample size calculation. The level of significance
will be set at p < 0.05. Descriptive statistics will be used
Table 1 Schedule for enrolment, data collection, interventions and outcome measures
Enrolment Allocation Post allocation
Timepoint ICU admission ICU stay (daily) ICU discharge Hospital discharge 6-month follow-up
Enrolment:
Eligibility screen x
Consent by nonparticipating doctor x
Allocation x
Informed consent by proxy ≤72 h
Data collection:
Demographic and diagnostic data x
APACHE II score x
SOFA score x
TISS 28 and 76 x x
Laboratory findings x x x
Medication x
Physiotherapy Interventions:
Frequency, duration and content x
Safety and physiological parameters x
Mobility milestones x
Bed rest complications x
Serious/adverse events x
Outcome measures:
Muscle strength: MRC sum score, handgrip
and quadriceps strength
x
Range of motion x
Functional Independence Measure x x
Length of stay (ICU and hospital), days on
mechanical ventilation
x
6-Minute Walk Test x
Timed ‘Up & Go’ Test x
Short Form 36 x
APACHE Acute Physiology and Chronic Health Evaluation, ICU intensive care unit, MRC Medical Research Council, SOFA Sequential Organ Failure Assessment score,
TISS Therapeutic Intervention Scoring System
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to describe mean outcomes and distribution. Subse-
quently, the outcome parameters between the two
groups will be compared using Student’s t tests for
normally distributed data and the Mann-Whitney U
test for nonnormal distribution. For repetitive data re-
peated measures analysis of variance (ANOVA) will be
deployed and for correlations between variables the
Spearman correlation coefficients or similar will be
used. If missing data are more than 5 %, multiple impu-
tations will be performed. There will be one planned
interim analysis after enrolment of 35 patients for as-
sessment of safety.
Discussion
This prospective, single-centre, allocation-concealed and
assessor-blinded randomised controlled trial with 6-
month follow-up will be the first, to our knowledge, to
evaluate both an early endurance and resistance training
compared to standard care in the mechanically venti-
lated, critically ill patient from a general ICU population.
Considering the devastating consequences of ICUAW, it
is imperative to find interventions that improve function
and thereby quality of life. The two chosen primary out-
comes, 6MWT and FIM, reflect these important physical
impairments of ICUAW, and thus have a high clinical
relevance for patients surviving prolonged mechanical
ventilation. Therefore, the strengths of this trial lie in
the pragmatic design of the early initiation and
physiotherapy-driven protocol, the prospective inclusion
of patients at risk of prolonged mechanical ventilation
and its consequences in the form of ICUAW in a wide
general ICU population that will be screened for study
recruitment within 12 h after ICU admission and will,
therefore, be enrolled very early into the trial, as well as
the everyday significance of the chosen outcome meas-
ure to the participants up to 6 months after hospital dis-
charge. If the experimental intervention should prove
superior to standard care, it will be relatively simple to
incorporate the intervention protocol into daily routine
so that it can be used elsewhere or for guideline devel-
opment. Limitations of this study are the heterogeneity
of the critically ill and the discontinuity of the protocol
after relocation to the other wards within the hospital.
Also, due to the trial’s nature, it is impossible to blind
the treating physiotherapists, ICU staff and the partici-
pants to the intervention. However, the outcome asses-
sors will be blinded to group allocation. Finally, the
reporting of adverse events during therapy will depend
on the treating physiotherapists, which could lead to
missing events. However, physiotherapists have been
carefully trained and work closely with the ICU nurse at
the bedside. Moreover, all safety parameters will be
continuously recorded by the PDMS for further safety
analysis.
Trial status
The first patient was randomised on 10 October 2012.
Recruitment is presently still ongoing, but should be
completed by the end of February 2016. Allowing for the
6-month follow-up after hospital discharge, we antici-
pate the end of the study in August 2016.
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